Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rosario Francesco Di Stefano"'
Autor:
Fabio Turco, Marcello Tucci, Marco Donatello Delcuratolo, Rosario Francesco Di Stefano, Chiara Pisano, Alessandro Audisio, Marco Audisio, Antonio Ungaro, Cinzia Ortega, Massimo Di Maio, Giorgio Vittorio Scagliotti, Consuelo Buttigliero
Publikováno v:
Cancer Communications, Vol 42, Iss 8, Pp 683-688 (2022)
Externí odkaz:
https://doaj.org/article/d06654afbb024f619266ea998729db80
Autor:
Marco Audisio, Consuelo Buttigliero, Fabio Turco, Marco Donatello Delcuratolo, Chiara Pisano, Elena Parlagreco, Rosario Francesco Di Stefano, Lavinia Di Prima, Veronica Crespi, Giovanni Farinea, Massimiliano Cani, Marcello Tucci
Publikováno v:
Cells, Vol 11, Iss 10, p 1614 (2022)
Urothelial cancer is a lethal malignancy characterized by a wide diffusion in Western countries due to a larger exposure to known risk factors, such as aromatic amines, tobacco smoke and benzene [...]
Externí odkaz:
https://doaj.org/article/12d9efc0cf6a48a38ae1daa47ecc4784
Autor:
Alessandro Audisio, Consuelo Buttigliero, Marco Donatello Delcuratolo, Elena Parlagreco, Marco Audisio, Antonio Ungaro, Rosario Francesco Di Stefano, Lavinia Di Prima, Fabio Turco, Marcello Tucci
Publikováno v:
Cells, Vol 11, Iss 3, p 357 (2022)
Non-muscle-invasive bladder cancer (NMIBC) is characterized by a high rate of cure, but also by a non-negligible probability of recurrence and risk progression to muscle-invasive disease. NMIBC management requires a proper local resection and staging
Externí odkaz:
https://doaj.org/article/6e7a10f94ebb48bd91d7f07029d690b5
Autor:
Fabio Turco, Marcello Tucci, Tiziana Angusti, Antonella Parente, Rosario Francesco Di Stefano, Susanna Urban, Chiara Pisano, Alessandro Samuelly, Alessandro Audisio, Marco Audisio, Elena Parlagreco, Antonio Ungaro, Giorgio Vittorio Scagliotti, Massimo Di Maio, Consuelo Buttigliero
Publikováno v:
Tumori Journal. 109:233-243
Background: Radium 223 (Ra-223) was approved for the treatment of metastatic castration resistant prostate cancer (mCRPC) patients with bone-only disease, following demonstration of significant improvement in overall survival (OS). To date, there are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e419105ba52787f998d7dabf03d536b
https://doi.org/10.1177/03008916221077144
https://doi.org/10.1177/03008916221077144
Autor:
Fabio Turco, Lavinia Di Prima, Chiara Pisano, Stefano Poletto, Marco De Filippis, Veronica Crespi, Giovanni Farinea, Massimiliano Cani, Mariangela Calabrese, Isabella Saporita, Rosario Francesco Di Stefano, Marcello Tucci, Consuelo Buttigliero
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50e98cf9daef6942afb2c2eb4d9276de
https://hdl.handle.net/2318/1893658
https://hdl.handle.net/2318/1893658
Autor:
Marco Audisio, Marcello Tucci, Rosario Francesco Di Stefano, Elena Parlagreco, Antonio Ungaro, Fabio Turco, Alessandro Audisio, Lavinia Di Prima, Cinzia Ortega, Massimo Di Maio, Giorgio Vittorio Scagliotti, Consuelo Buttigliero
Publikováno v:
Critical reviews in oncology/hematology. 174
In recent years the introduction of immunotherapy has importantly changed the treatment landscape of advanced urothelial carcinoma. Several immune checkpoint inhibitors are now the standard of care as maintenance treatment after disease control with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa42cc81c954da8b689673ed37cea14b
https://pubmed.ncbi.nlm.nih.gov/35421529
https://pubmed.ncbi.nlm.nih.gov/35421529